Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by SLAS. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by SLAS or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The MO:BOT from mo:re | SLAS Europe 2025 New Product Award Winner with Lukas Gaats, MBA, MSc

12:38
 
Share
 

Manage episode 507798966 series 3279354
Content provided by SLAS. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by SLAS or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Send us a text

Live from SLAS Europe 2025 in Hamburg, host Emily Yamasaki, PhD, speaks with Lukas Gaats, MBA, MSc, CEO of mo:re (Modern Research) who is a winner of the SLAS Europe 2025 New Product Award. Based in Hamburg, mo:re is revolutionizing 3D cell culture automation with a modular, biology-first platform designed for organoids, spheroids, and tumor models.

Lukas shares his journey from academia (studying regenerative medicine and bioprinting in Australia) to founding mo:re after identifying the need for standardized, reproducible 3D cell cultures. Frustrated by the variability in manual techniques, the company developed a modular robotic system that integrates hardware, software and wetware (biology protocols).

The MO:BOT is a user-friendly robotic and software platform that sets a new benchmark for medical research studies. It utilizes automation and AI to enhance cell survival and consistency, even in long-term studies, resulting in improved traceability and reproducibility for research and regulatory purposes.

Learn more about mo:re by visiting:
more.science

Key Highlights:

  • SLAS Innovation AveNEW Roots: mo:re’s 2023 debut as a prototype evolved into a commercialized platform, now backed by seed funding.
  • FDA’s Animal Testing Phase-Out: Lukas discusses how this regulatory shift boosts demand for human-relevant 3D models.
  • Hamburg’s Biotech Scene: An emerging hub with talent from EMBL and Fraunhofer, though still nascent for startups.

Stay connected with SLAS:

About SLAS
SLAS (Society for Laboratory Automation and Screening) is an international professional society of academic, industry and government life sciences researchers and the developers and providers of laboratory automation technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global

SLAS2026 International Conference & Exhibition

  • February 7-11, 2026
  • Boston, MA

SLAS Europe 2026 Conference and Exhibition

  • 19-21 May 2026
  • Vienna, Austria

View the full events calendar

  continue reading

189 episodes

Artwork
iconShare
 
Manage episode 507798966 series 3279354
Content provided by SLAS. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by SLAS or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Send us a text

Live from SLAS Europe 2025 in Hamburg, host Emily Yamasaki, PhD, speaks with Lukas Gaats, MBA, MSc, CEO of mo:re (Modern Research) who is a winner of the SLAS Europe 2025 New Product Award. Based in Hamburg, mo:re is revolutionizing 3D cell culture automation with a modular, biology-first platform designed for organoids, spheroids, and tumor models.

Lukas shares his journey from academia (studying regenerative medicine and bioprinting in Australia) to founding mo:re after identifying the need for standardized, reproducible 3D cell cultures. Frustrated by the variability in manual techniques, the company developed a modular robotic system that integrates hardware, software and wetware (biology protocols).

The MO:BOT is a user-friendly robotic and software platform that sets a new benchmark for medical research studies. It utilizes automation and AI to enhance cell survival and consistency, even in long-term studies, resulting in improved traceability and reproducibility for research and regulatory purposes.

Learn more about mo:re by visiting:
more.science

Key Highlights:

  • SLAS Innovation AveNEW Roots: mo:re’s 2023 debut as a prototype evolved into a commercialized platform, now backed by seed funding.
  • FDA’s Animal Testing Phase-Out: Lukas discusses how this regulatory shift boosts demand for human-relevant 3D models.
  • Hamburg’s Biotech Scene: An emerging hub with talent from EMBL and Fraunhofer, though still nascent for startups.

Stay connected with SLAS:

About SLAS
SLAS (Society for Laboratory Automation and Screening) is an international professional society of academic, industry and government life sciences researchers and the developers and providers of laboratory automation technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global

SLAS2026 International Conference & Exhibition

  • February 7-11, 2026
  • Boston, MA

SLAS Europe 2026 Conference and Exhibition

  • 19-21 May 2026
  • Vienna, Austria

View the full events calendar

  continue reading

189 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play